Filing Flows › Novartis AG (NVS) › Operating margin
Novartis AG (NVS) operating margin by quarter
Novartis AG's operating margin was 12.7% in Q3 2026 (third quarter 2026), -20.3 pts from Q2 2026. Over the last 6 quarters it ranged from 12.7% (Q3 2026) to 34.6% (Q2 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 12.7% | -20.3 pts | -19.7 pts |
| Q2 2026 | 33.0% | +0.7 pts | -1.6 pts |
| Q1 2026 | 32.3% | +5.2 pts | — |
| Q4 2025 | 27.1% | -5.2 pts | — |
| Q3 2025 | 32.4% | -2.2 pts | — |
| Q2 2025 | 34.6% | — | — |
Q3 2026 at a glance
Novartis AG, Q3 2026: revenue $14.5B (+4% year over year), operating margin 12.7%, net earnings $1.2B, operating cash flow $5.5B. The chart follows the revenue to costs, profit and cash.
Questions
What is Novartis AG's operating margin?
Novartis AG's operating margin was 12.7% in Q3 2026 (third quarter 2026), -20.3 pts from Q2 2026.
How has Novartis AG's operating margin changed?
Over the last 6 quarters it ranged from 12.7% (Q3 2026) to 34.6% (Q2 2025).